Dividend compounder review

VCEL

Vericel Corp Ord · NASDAQ · US

Healthcare · Biotechnology

Score44.00/100
Confidence82.00/100
DecisionInsufficient Data
RatingAvoid
Scoring

Quality breakdown

Dividend Reliability 0.0 / 25 Payment history, cuts, growth, and regularity.
Dividend Sustainability 17.0 / 20 Payout, free cash flow, dividend cover, and debt.
Business Quality 19.5 / 25 Scale, cash generation, growth, margins, and returns.
Valuation Discipline 3.5 / 15 Yield, P/E, and price stretch versus long-term trend.
Long-Term Trend 4.0 / 15 Trend line, long return history, and drawdown control.
Metrics

Dividend and business context

Dividend Years0
Dividend Yield0.00%
Payout Ratio0.0%
Dividend Cut 5YNo
Net Income$16.5M
Free Cash Flow$24.7M
FCF Covers DividendUnknown
Debt / Equity0.27
P/E93.9
Revenue Growth 5Y6.9%
Net Margin7.3%
ROE6.6%
Price vs Trend13.4%
3Y Return13.0%
5Y Return-23.9%
CurrencyUSD
Warnings

Review flags

No usable dividend history found.
Dividend diary

Activity record

VCEL dividend review warning Warning · Warning

No usable dividend history found.